Immortal Dragons has launched with $40 million to support longevity research
Longevity Technology - 18-Jul-2025The fund bridges East-West collaboration and acts quickly using its own capital
Danny Sullivan
Contributing editor to Longevity Technology
Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
Details last updated 10-Feb-2020
Articles written by Danny Sullivan
Mito Fund invests in Pretzel Therapeutics for mitochondrial disease therapies
Longevity Technology - 15-Jul-2025New investment fuels development of therapies targeting mtDNA-related energy disorders
Epigenica debuts scalable tech to track epigenetic ageing
Longevity Technology - 04-Jul-2025Epigenica launches scalable tech to decode epigenetic ageing and disease markers
Outsee raises 1.8m for AI genomics in drug discovery
Longevity Technology - 25-Jun-2025Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets
Infinity Bio raises $8m to decode the antibody reactome
Longevity Technology - 24-Jun-2025Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing
Parallel Bio raises $21m to replace animal testing with human immune organoids
Longevity Technology - 17-Jun-2025New platform aims to cut drug discovery by $2B and 9 years using lab-grown human immune models
Juvena strikes $650m deal with lilly to tackle obesity
Longevity Technology - 11-Jun-2025AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss
AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition
Longevity Technology - 05-Jun-2025Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push
AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost
Longevity Technology - 30-May-2025Biotech firm uses AI and robotics to test drugs on real human tissues, not animals
Neuralink raised $600 million, reaching a $9 billion valuation
Longevity Technology - 28-May-2025The company is still in early stages but attracting strong investor interest
Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition
Longevity Technology - 23-May-2025Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
AI startup Somite raises $47m to revolutionize stem cell therapy
Longevity Technology - 16-May-2025Somite AI uses DeltaStem to speed up and scale stem cell engineering
BrightFocus Foundation fuels early research on aging diseases with $13m grants
Longevity Technology - 13-May-2025Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma
Rewriting the cell's code: HAYA’s mission to transform genomic medicine
Longevity Technology - 12-May-2025Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states
Hundred health acquires BellSant to supercharge AI longevity platform strapline:
Longevity Technology - 08-May-2025AI-driven health platform gears up for launch with cutting-edge longevity data
NewLimit secures $130m to accelerate epigenetic reprogramming for longevity
Longevity Technology - 06-May-2025The biotech company aims to target the root causes of ageing to develop therapies to extend lifespan
Breakthrough drug targets liver regeneration with 21.5m boost
Longevity Technology - 17-Apr-2025HepaRegeniX advances trials for a novel liver regeneration therapy
Science corp secures major funding to restore sight with BCI tech
Longevity Technology - 15-Apr-2025A next-gen retinal implant offers new hope for vision loss from macular degeneration
New drug for Parkinson’s may keep symptoms under control with just weekly injections
Longevity Technology - 09-Apr-2025It avoids common delivery problems and enters Phase 1 trials in 2025
Tribune Therapeutics secures 37m to tackle fibrosis at its source
Longevity Technology - 28-Mar-2025Scandinavian biotech targets fibrosis with novel scar-blocking therapies
Display all articles
